drugset / Trial / NCT06568094
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy, and safety of HRS-5041 tablets combined with antitumor therapy in subjects with advanced prostate cancer.
Timeline
- Start
- 2024-09-25
- Primary completion
- 2026-06
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | — | — |
| Subject | Darolutamide | Other / unclassified | — | — |
| Subject | Docetaxel | Small molecule | — | — |
| Subject | HRS-1167 | Unknown | — | — |
| Subject | HRS-5041 | Other / unclassified | — | — |
| Subject | HRS-6208 | Unknown | — | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | SHR2554 | Small molecule | — | — |